These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools. Scott JA; Jones AM; Jokl E; Gordon-Walker T; Barry PJ; Hanley NA; Piper Hanley K; Athwal VS Heliyon; 2023 Nov; 9(11):e21861. PubMed ID: 38053913 [TBL] [Abstract][Full Text] [Related]
10. Cystic Fibrosis Liver Disease: Know More. Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411 [TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes. Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930 [TBL] [Abstract][Full Text] [Related]
14. Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study. Baldissera M; Lewindon PJ; Ramm LE; Hartel GF; Mattiello R; Ramm GA J Cyst Fibros; 2022 Mar; 21(2):230-235. PubMed ID: 34949555 [TBL] [Abstract][Full Text] [Related]
15. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population. Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979 [TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study. Squirell E; Lockyer J Can Liver J; 2021; 4(1):33-37. PubMed ID: 35991469 [TBL] [Abstract][Full Text] [Related]